The Immune-microenvironment Confers Chemoresistance of Colorectal Cancer through Macrophage-Derived IL6
Published version of a preprint
The DOI matches its Crossref record; 52 of the 54 references it cites were found in a registry or an index.
Abstract
Purpose: Tumor-associated macrophages (TAMs) are frequently associated with poor prognosis in human cancers. However, the effects of TAMs in colorectal cancer are contradictory. We therefore investigated the functions, mechanisms, and clinical significance of TAMs in colorectal cancer. Experimental Design: We measured the macrophage infiltration (CD68), P-gp, and Bcl2 expression in colorectal cancer tissues using IHC staining. Coculture of TAMs and colorectal cancer cells both in vitro and in vivo models was used to evaluate the effects of TAMs on colorectal cancer chemoresistance. Cytokine antibody arrays, ELISA, neutralizing antibody, and luciferase reporter assay were performed to uncover the underlying mechanism. Results: TAM infiltration was associated with chemoresistance in patients with colorectal cancer. Colorectal cancer–conditioned macrophages increased colorectal cancer chemoresistance and reduced drug-induced apoptosis by secreting IL6, which could be blocked by a neutralizing anti-IL6 antibody. Macrophage-derived IL6 activated the IL6R/STAT3 pathway in colorectal cancer cells, and activated STAT3 transcriptionally inhibited the tumor suppressor miR-204-5p. Rescue experiment confirmed that miR-204-5p is a functional target mediating the TAM-induced colorectal cancer chemoresistance. miR-155-5p, a key miRNA regulating C/EBPβ, was frequently downregulated in TAMs, resulting in increased C/EBPβ expression. C/EBPβ transcriptionally activated IL6 in TAMs, and TAM-secreted IL6 then induced chemoresistance by activating the IL6R/STAT3/miR-204-5p pathway in colorectal cancer cells. Conclusions: Our data indicate that the maladjusted miR-155-5p/C/EBPβ/IL6 signaling in TAMs could induce chemoresistance in colorectal cancer cells by regulating the IL6R/STAT3/miR-204-5p axis, revealing a new cross-talk between immune cells and tumor cells in colorectal cancer microenvironment. Clin Cancer Res; 23(23); 7375–87. ©2017 AACR.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In stage III CRC patients treated with 5-FU, L-OHP and leucovorin, high TAM (CD68) density is associated with treatment insensitivity.”
From Drug Resistance in Colorectal Cancer: From Mechanism to Clinic (2022) · cites this paper as [326]
In the citing paper
“TAM-derived IL6 induces CRC chemotherapy resistance by activating the IL6R/STAT3/miR-204-5p axis”
From Drug Resistance in Colorectal Cancer: From Mechanism to Clinic (2022) · cites this paper as [326]
In the citing paper
“which can be reversed by miR-204-5P overexpression or IL6 blockers [326].”
From Drug Resistance in Colorectal Cancer: From Mechanism to Clinic (2022) · cites this paper as [326]
Citations
Cites
Siegel, R. L., Miller, K. D., & Jemal, A. (2015) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21254 · Cited by 11,853
Denkert, C., Loibl, S., Noske, A., Roller, M., Müller, B. M., Komor, M., Budczies, J., Darb-Esfahani, S., Kronenwett, R., Hanusch, C., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.23.7370 · Cited by 1,762
DeNardo, D. G., Brennan, D. J., Rexhepaj, E., Ruffell, B., Shiao, S. L., Madden, S. F., Gallagher, W. M., Wadhwani, N., Keil, S. D., Junaid, S. A., et al. (2011) · Cancer Discovery · doi:10.1158/2159-8274.cd-10-0028 · Cited by 1,715 · cited 1×
“It has been reported that TAMs suppress CD8þ T lymphocyte activity and then promote chemoresistance to paclitaxel and metastasis in mammary tumors (41).”
BackgroundTumor-Associated Macrophages as Major Players in the Tumor Microenvironment
Chanmee, T., Ontong, P., Konno, K., & Itano, N. (2014) · Cancers · doi:10.3390/cancers6031670 · Cited by 1,538 · cited 1×
“Tumor-associated macrophages (TAMs) are one of the most abundant types of cells in TME, directly affecting tumor progression in many cases (3).”
BackgroundIL-6R/STAT3/miR-34a feedback loop promotes EMT-mediated colorectal cancer invasion and metastasis
Rokavec, M., Öner, M. G., Li, H., Jackstadt, R., Jiang, L., Lodygin, D., Kaller, M., Horst, D., Ziegler, P. K., Schwitalla, S., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci73531 · Cited by 753
Iliopoulos, D., Hirsch, H. A., Wang, G., & Struhl, K. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1018898108 · Cited by 643
High Macrophage Infiltration along the Tumor Front Correlates with Improved Survival in Colon Cancer
Forssell, J., Öberg, A., Henriksson, M. L., Stenling, R., Jung, A., & Palmqvist, R. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-2073 · Cited by 566 · cited 1×
“However, increased macrophage infiltration was also reported to correlate with improved survival in colorectal cancer (17, 18).”
BackgroundMacrophages and cathepsin proteases blunt chemotherapeutic response in breast cancer
Shree, T., Olson, O. C., Elie, B. T., Kester, J. C., Garfall, A. L., Simpson, K., Bell-McGuinn, K. M., Zabor, E. C., Brogi, E., & Joyce, J. A. (2011) · Genes & Development · doi:10.1101/gad.180331.111 · Cited by 541 · cited 1×
“For example, Shree and colleagues showed that macrophages protect breast cancer cells from cell death induced by taxol, etoposide, and doxorubicin (8).”
BackgroundKorkaya, H., Kim, G.-I., Davis, A., Malik, F., Henry, N. L., Ithimakin, S., Quraishi, A. A., Tawakkol, N., D'Angelo, R., Paulson, A. K., et al. (2012) · Molecular Cell · doi:10.1016/j.molcel.2012.06.014 · Cited by 538
Role for miR-204 in human pulmonary arterial hypertension
Courboulin, A., Paulin, R., Giguère, N. J., Saksouk, N., Perreault, T., Meloche, J., Paquet, E. R., Biardel, S., Provencher, S., Côté, J., et al. (2011) · Journal of Experimental Medicine · doi:10.1084/jem.20101812 · Cited by 523 · cited 1×
“Activated Stat3 can bind to three putative STAT-binding sites located in the TRPM3/miR-204 promoter region, leading to the transcriptional repression ofmiR-204 (29, 30).”
Background
Cited by
Tumor-associated macrophages: an accomplice in solid tumor progression
Chen, Y., Song, Y., Du, W., Gong, L., Chang, H., & Zou, Z. (2019) · Journal of Biomedical Science · doi:10.1186/s12929-019-0568-z · Cited by 1,096
Wei, C., Yang, C., Wang, S., Shi, D., Zhang, C., Lin, X., Liu, Q., Dou, R., & Xiong, B. (2019) · Molecular Cancer · doi:10.1186/s12943-019-0976-4 · Cited by 833
Wang, S., Wang, J., Chen, Z., Luo, J., Guo, W., Sun, L., & Lin, L. (2024) · npj Precision Oncology · doi:10.1038/s41698-024-00522-z · Cited by 569
“MiR-155-5pinTAMs 84 canactivatethe IL-6R/STAT3/miR-204-5ppathwayincolorectalcancer(CRC)toinduce tumorchemoresistancebyregulatingC/EBP β .”
The multi-factorial nature of clinical multidrug resistance in cancer
Assaraf, Y. G., Brozovic, A., Gonçalves, A. C., Jurkovicova, D., Linē, A., Machuqueiro, M., Saponara, S., Sarmento-Ribeiro, A. B., Xavier, C. P. R., & Vasconcelos, M. H. (2019) · Drug Resistance Updates · doi:10.1016/j.drup.2019.100645 · Cited by 528
“In CRC patients undergoing surgery and standardized chemotherapy, a strong TAM infiltration was associated with resistance to therapy (Yin et al., 2017).”
BackgroundErin, N., Grahovac, J., Brozovic, A., & Efferth, T. (2020) · Drug Resistance Updates · doi:10.1016/j.drup.2020.100715 · Cited by 527
Metadata
- Authors
- Yin, Y., Yao, S., Hu, Y., Feng, Y., Li, M., Bian, Z., Zhang, J., Qin, Y., Qi, X., Zhou, L., Fei, B., Zou, J., Hua, D., & Huang, Z.
- Affiliations
- Wuxi Fourth People's Hospital (CN)
- Wuxi People's Hospital (CN)
- Corresponding author
- Huang, Zhaohui
- ORCID
- Venue
- Clinical Cancer Research
- Published
- 2017-11-30
- Volume
- 23
- Issue
- 23
- Pages
- 7375-7387
- ISSN
- 1078-0432 (ISSN-L)
- 1557-3265
- OpenAlex
- W2757812515
- Cited by
- 296
- References
- 54
- Citations by year
- 2026: 24 · 2025: 25 · 2024: 34 · 2023: 37 · 2022: 58 · 2021: 42 · 2020: 41 · 2019: 23 · 2018: 12
- FWCI
- 9.43
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Clinical Cancer Research (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Keywords
- colorectal cancer, tumor-associated macrophages, chemoresistance, interleukin-6, miR-204-5p, miR-155-5p, C/EBPβ, tumor microenvironment, drug-induced apoptosis, P-glycoprotein, Bcl-2
- MeSH terms
- RAW 264.7 Cells, Oxaliplatin, Animals, Antineoplastic Agents, Cell Survival, Female, Fluorouracil, Humans, Immune System, Macrophages, Male, Middle Aged, Organoplatinum Compounds, Colorectal Neoplasms, Interleukin-6, Gene Expression Regulation, Neoplastic, Drug Resistance, Neoplasm, HT29 Cells, MicroRNAs, Cell Line, Tumor, Mice, Tumor Microenvironment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The Immune-microenvironment Confers Chemoresistance of Colorectal Cancer through Macrophage-Derived IL6. https://app.cochat.ai/papers/10.1158/1078-0432.ccr-17-1283
- The paper
- Yin, Y., Yao, S., Hu, Y., Feng, Y., Li, M., Bian, Z., Zhang, J., Qin, Y., Qi, X., Zhou, L., Fei, B., Zou, J., Hua, D., & Huang, Z. (2017). The Immune-microenvironment Confers Chemoresistance of Colorectal Cancer through Macrophage-Derived IL6. Clinical Cancer Research. https://doi.org/10.1158/1078-0432.ccr-17-1283
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.